RxDoctor Payments Data

Joseph Kavolus, MD

Orthopaedic Surgery · Boston, MANPI 1831432400

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $41,975 of the $69,370 with a category attached, or 60.5%. 12 manufacturers reported payments, led by Microport Navibot International LLC at 39.1% of the total. Reporting peaked in 2023 at $37,765 and has fallen 92.2% since, to $2,953 in 2025. Among orthopaedic surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$69,370in general payments, 2019–2025

Across 276 payments — averaging $251.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microport Navibot International LLC$27K
  • Omnilife Science, Inc$23K
  • Stryker$7K
  • Microport Orthopedics Inc$7K
  • Zimmer Biomet$2K
  • Medacta USA, Inc.$2K
  • plus $711 from 6 others

What the payments were for

  • Consulting fees$41,97561%
  • Speaking & faculty fees$13,00019%
  • Travel & lodging$6,5829%
  • Food & beverage$7,81311%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,370 in reported general payments places this provider in the 90th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$474,672
Medicare patients
661
Services billed
15,531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib28$417
Diclofenac Sodium13$135
Methylprednisolone12$99
Prednisone36$56

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →